Royalty Pharma plc (RPRX)
| Previous close | 27.82 |
| Open | 27.90 |
| Bid | 27.81 x 700 |
| Ask | 27.89 x 100 |
| Day's range | 27.60 - 27.97 |
| 52-week range | 25.92 - 35.76 |
| Volume | |
| Avg. volume | 2,745,059 |
| Market cap | 16.633B |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 11.00 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.84 (3.02%) |
| Ex-dividend date | 16 May 2024 |
| 1y target est | N/A |
- GlobeNewswire
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2024 financial results on Thursday, May 9, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day. Conference Call Information Please visit the “Investors” page of the company’s website at https://www.royaltypharma.com/investors/events/ to obtain conference call information an
- GlobeNewswire
Royalty Pharma Declares Second Quarter 2024 Dividend
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2024 of $0.21 per Class A ordinary share. The dividend will be paid on June 14, 2024, to shareholders of record at the close of business on May 17, 2024. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industr
- GlobeNewswire
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at TD Cowen’s 44th Annual Health Care Conference on March 5, 2024 at 10:30 a.m. ET. The webcast will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/events/. The webcast will also be archived for a minimum of thirty days. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical
